Spots Global Cancer Trial Database for human papillomavirus infection
Every month we try and update this database with for human papillomavirus infection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) | NCT02653118 | Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papilloma... | V503 GARDASIL | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt | NCT01158209 | Human Papilloma... | Endocervical sa... | 18 Years - | GlaxoSmithKline | |
| Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention | NCT01588301 | Cervical Cancer Human Papilloma... | Attending for c... Kit for Self-co... | 30 Years - 65 Years | University Hospital, Tours | |
| Lubricant Investigation in Men to Inhibit Transmission of HPV Infection | NCT02354144 | Human Papilloma... | Carrageenan-bas... Control gel | 18 Years - | McGill University | |
| Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System | NCT01694875 | Human Papilloma... | APTIMA HPV Assa... | 21 Years - | Gen-Probe, Incorporated | |
| Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia | NCT04411849 | Cervical Carcin... Human Papilloma... | Best Practice HPV Self-Collec... Informational I... Patient Navigat... | 30 Years - 64 Years | Ohio State University Comprehensive Cancer Center | |
| Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV | NCT04587050 | HIV Infections Human Papilloma... Cervical Cancer | Human papilloma... Cervical cytolo... HPV serology | 18 Years - | Imperial College London | |
| Serum Galectin-3 as a Marker of Human Papillomavirus Infection | NCT06005389 | Human Papilloma... | cryotherapy serum Galectin-... | 18 Years - 60 Years | Assiut University | |
| APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results | NCT01384370 | Human Papilloma... | 18 Years - | Gen-Probe, Incorporated | ||
| Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts | NCT05156541 | Human Papilloma... Anogenital Wart... | Interferon gamm... | 18 Years - 50 Years | SPP Pharmaclon Ltd. | |
| Efficacy and Safety of Carboxymethyl Beta-glucan and Policarbophil in HPV Positive Patients | NCT06199128 | Human Papilloma... | carboxymethyl β... | 25 Years - 65 Years | Uriach Consumer Healthcare | |
| Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana | NCT03345875 | Human Papilloma... Cervical Cancer | HPV self collec... | 30 Years - 49 Years | Jhpiego | |
| A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand | NCT03302858 | HSIL, High Grad... Anal Cancer HPV-Related Squ... Human Papilloma... Human Papilloma... Ain III | BARRX™ Anorecta... | 18 Years - 75 Years | Laser Surgery Care | |
| Phase I Clinical Trial of a Candidate HPV Vaccine | NCT05672966 | Human Papilloma... | Human papilloma... Placebo | 18 Years - 35 Years | Wuhan BravoVax Co., Ltd. | |
| Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV | NCT04587050 | HIV Infections Human Papilloma... Cervical Cancer | Human papilloma... Cervical cytolo... HPV serology | 18 Years - | Imperial College London | |
| Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer | NCT02827838 | Human Papilloma... Stage I Oral Ca... Stage I Orophar... Stage II Oral C... Stage II Oropha... Stage III Oral ... Stage III Oroph... Stage IVA Oral ... Stage IVA Oroph... Stage IVB Oral ... Stage IVB Oroph... Stage IVC Oroph... | Durvalumab Laboratory Biom... Therapeutic Con... | 18 Years - | Wake Forest University Health Sciences | |
| A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China | NCT05662020 | Human Papilloma... | Recombinant Non... GARDASIL® 9 | 9 Years - 26 Years | Beijing Health Guard Biotechnology, Inc | |
| Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers | NCT01087164 | Human Papilloma... | Compliance Message sidedne... | 11 Years - 15 Years | Indiana University | |
| Human Papillomavirus Infection and Virus Genotyping in Uterine Cervix Cancer in Venezuela | NCT00937547 | Cervical Cancer | - | Instituto Oncologico Luis Razetti | ||
| Agreement of hrHPV Type Between Self-collected Sample From Vaginal Fornix and Physician Collected Sample From the Cervical Surface | NCT04472377 | Human Papilloma... Self Sampling Vaginal Dischar... | Self sampling k... | 21 Years - 65 Years | Hygeia Touch Inc. | |
| Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) | NCT00520598 | Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papilloma... | Comparator: V50... Comparator: V50... Comparator: V50... Comparator: V50... Comparator: Qua... Comparator: Pla... | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers | NCT02355262 | Breast Carcinom... Cervical Carcin... Colorectal Carc... Health Status U... Human Papilloma... Malignant Neopl... | Informational I... | 18 Years - | OHSU Knight Cancer Institute | |
| HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population | NCT05981807 | Human Papilloma... Human Immunodef... Sexually Transm... | 18 Years - | ANRS, Emerging Infectious Diseases | ||
| Research in Ethno-Medicine and Education (REMED) | NCT05907187 | Cervical Cancer Human Papilloma... HPV Human Papilloma... | Cervical Cancer... | 18 Years - | University of Miami | |
| Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention | NCT01588301 | Cervical Cancer Human Papilloma... | Attending for c... Kit for Self-co... | 30 Years - 65 Years | University Hospital, Tours | |
| A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005) | NCT00988884 | Human Papilloma... | V503 Comparator: Men... Comparator: Ada... Comparator: Men... Comparator: Ada... | 11 Years - 15 Years | Merck Sharp & Dohme LLC | |
| Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities | NCT00501189 | Papillomavirus ... | human papilloma... | 18 Years - 26 Years | Eisenhower Army Medical Center | |
| The Human Papillomavirus (HPV) Transmission Pilot Study | NCT00823511 | Human Papilloma... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | ||
| Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection | NCT00508170 | Head and Neck C... Oropharyngeal C... Human Papilloma... | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer | NCT01932697 | Human Papilloma... Stage I Orophar... Stage II Oropha... Stage III Oroph... Stage IVA Oroph... Stage IVB Oroph... | Docetaxel Hyperfractionat... Intensity-Modul... Laboratory Biom... Quality-of-Life... | 18 Years - | Mayo Clinic | |
| Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccination | NCT01082861 | Human Papilloma... | Cervarix Engerix-B | 11 Years - 12 Years | National Institute for Public Health and the Environment (RIVM) | |
| HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults | NCT04474821 | Human Papilloma... Human Papilloma... | Educational Int... Survey Administ... | 18 Years - 45 Years | Mayo Clinic | |
| Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology | NCT04369339 | Human Papilloma... | Colposcopy | 18 Years - 65 Years | Bezmialem Vakif University | |
| A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection | NCT02785289 | Human Papilloma... | Vaginal swab | 21 Years - 65 Years | University Hospital, Geneva | |
| A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents | NCT00518180 | Meningococcal M... Human Papilloma... Pertussis Tetanus | Novartis Mening... Tdap Vaccine Novartis Mening... | 11 Years - 18 Years | Novartis | |
| The Human Papilloma Virus Effect on Sexual Life | NCT03837028 | Human Papilloma... | FSFI | 30 Years - 50 Years | Bakirkoy Dr. Sadi Konuk Research and Training Hospital | |
| Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana | NCT03345875 | Human Papilloma... Cervical Cancer | HPV self collec... | 30 Years - 49 Years | Jhpiego | |
| HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix | NCT04333212 | Cervical Intrae... Human Papilloma... HPV Infection | DR. Chip HPV ge... | 21 Years - 65 Years | Chang Gung Memorial Hospital | |
| Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study | NCT04660331 | Human Papilloma... | Communication I... Communication S... Healthcare Acti... Healthcare Acti... Survey Administ... | 18 Years - | Fred Hutchinson Cancer Center | |
| Primary Cervical Cancer Screening by Self-sampling HPV Test | NCT05613283 | Human Papilloma... Cervical Cancer Negative For In... Atypical Squamo... Atypical Squamo... Cervical Squamo... Low-Grade Squam... High-Grade Squa... Cervical Intrae... Cervical Intrae... Cervical Intrae... Atypical Glandu... Atypical Glandu... Atypical Glandu... Cervical Squamo... Adenocarcinoma ... Cervical Adenoc... | 21 Years - 65 Years | Peking University People's Hospital | ||
| Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men | NCT04142398 | HIV Infection Human Papilloma... Human Papilloma... | Cytology Specim... High Resolution... Laboratory Biom... Medical Examina... Physical Examin... Questionnaire A... | 18 Years - | AIDS Malignancy Consortium | |
| Prospective Evaluation of Self-Testing to Increase Screening | NCT03898167 | Cervical Cancer Human Papilloma... | Telephone Recal... Mailed HPV Self... Patient Navigat... | 30 Years - 65 Years | Baylor College of Medicine | |
| Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study | NCT01824537 | Human Papilloma... | HPV vaccine, Ga... Hepatitis A vac... | 18 Years - 45 Years | McGill University | |
| Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy | NCT05860725 | Human Papilloma... Vaccination Hes... | PSA Development HPV vaccination... | 18 Years - | University of Virginia | |
| Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention | NCT03346915 | Human Papilloma... Cervical Cancer Human Papilloma... Oropharyngeal C... Vaginal Cancer Vulvar Cancer Anal Cancer Penile Cancer | WoW and BNI | 9 Years - 65 Years | Boston Medical Center | |
| Human Papillomavirus in Young People Epidemiological Research 3 | NCT05587725 | Human Papilloma... HPV HPV Infection Anal Cancer Cancer Men HPV 16 Infectio... | 16 Years - 20 Years | Monash University | ||
| Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients | NCT03036930 | Human Papilloma... | Biospecimen Col... HPV Self-Collec... Questionnaire A... Recombinant Hum... | 18 Years - 49 Years | National Cancer Institute (NCI) | |
| Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring | NCT05774561 | Cervical Cancer Cervical Dyspla... Oropharyngeal C... Human Papilloma... | Arm A - Diagnos... Arm B - Diagnos... | 18 Years - 99 Years | The Institute of Molecular and Translational Medicine, Czech Republic | |
| Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology | NCT04369339 | Human Papilloma... | Colposcopy | 18 Years - 65 Years | Bezmialem Vakif University | |
| The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases | NCT02188004 | Human Papilloma... Genital Warts | 18 Years - 55 Years | Xiamen University | ||
| Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka | NCT01551537 | Human Papilloma... | Cervarix data c... Data Collection | 10 Years - | GlaxoSmithKline | |
| Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial | NCT05237947 | Cervical Carcin... Human Papilloma... | Diphtheria Toxo... Questionnaire A... Recombinant Hum... Recombinant Hum... | 18 Years - 30 Years | National Cancer Institute (NCI) | |
| Phase I Clinical Trial of a Candidate HPV Vaccine | NCT05672966 | Human Papilloma... | Human papilloma... Placebo | 18 Years - 35 Years | Wuhan BravoVax Co., Ltd. | |
| Promoting HPV Vaccination Among Young Adults in Texas | NCT05057312 | Human Papilloma... | Enhancing Acces... Informational I... Informational I... Informational I... Interview Questionnaire A... | 18 Years - 26 Years | M.D. Anderson Cancer Center | |
| A Cohort Study for the Following up of Conization | NCT03961178 | Precancerous Le... Conization High Grade Intr... Uterine Cervica... Fertility Pregnancy Human Papilloma... | High-risk HPV TCT | 18 Years - | Peking Union Medical College Hospital | |
| Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study | NCT03309033 | Human Papilloma... Human Papilloma... | Biospecimen Col... Questionnaire A... | - | National Cancer Institute (NCI) | |
| Video-Assisted Counseling for HPV Vaccination | NCT03510091 | Human Papilloma... | Counseling | 9 Years - 99 Years | Le Bonheur Children's Hospital | |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients | NCT02724254 | Condyloma | AP611074 5% gel AP611074 matchi... | 18 Years - 55 Years | Vaxart | |
| Self-sampling for Non-attenders to Cervical Cancer Screening | NCT04226313 | Cervical Cancer Cervical Dyspla... Human Papilloma... | Self-sampling b... Self sampling b... | 30 Years - 65 Years | The Institute of Molecular and Translational Medicine, Czech Republic | |
| BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer | NCT02706691 | FGFR Gene Ampli... FGFR1 Gene Ampl... FGFR2 Gene Ampl... FGFR2 Gene Muta... FGFR3 Gene Muta... Head and Neck S... Human Papilloma... Recurrent Head ... Recurrent Nasop... Recurrent Oroph... | BGJ398 | 18 Years - | University of Chicago | |
| Comparison of Self-collection Using Dry Compared to Wet Swabs for HPV Detection | NCT06213051 | Human Papilloma... | • COPAN Self-co... | 30 Years - 80 Years | Foundation for Innovative New Diagnostics, Switzerland | |
| Impact of HPV Vaccination on Cervical High Grade Lesions in France | NCT04167501 | Human Papilloma... | biological samp... | 27 Years - 46 Years | Centre Hospitalier Universitaire de Besancon | |
| Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer | NCT02827838 | Human Papilloma... Stage I Oral Ca... Stage I Orophar... Stage II Oral C... Stage II Oropha... Stage III Oral ... Stage III Oroph... Stage IVA Oral ... Stage IVA Oroph... Stage IVB Oral ... Stage IVB Oroph... Stage IVC Oroph... | Durvalumab Laboratory Biom... Therapeutic Con... | 18 Years - | Wake Forest University Health Sciences | |
| Randomized Comparison of Vaginal Self Sampling for Human Papillomavirus (HPV) Testing by Standard Versus Dry Vaginal Swabs | NCT01316120 | Human Papilloma... | Compare differe... Compare differe... | 20 Years - | University Hospital, Geneva | |
| Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy | NCT05860725 | Human Papilloma... Vaccination Hes... | PSA Development HPV vaccination... | 18 Years - | University of Virginia | |
| Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual Trauma | NCT05458869 | Cervical Carcin... Human Papilloma... | HPV Self-Collec... Interview Survey Administ... | 25 Years - | OHSU Knight Cancer Institute | |
| Prospective Evaluation of Self-Testing to Increase Screening | NCT03898167 | Cervical Cancer Human Papilloma... | Telephone Recal... Mailed HPV Self... Patient Navigat... | 30 Years - 65 Years | Baylor College of Medicine | |
| A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine | NCT06207175 | Human Papilloma... | Nonavalent HPV ... GARDASIL® 9 | 18 Years - 45 Years | Beijing Health Guard Biotechnology, Inc | |
| A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010) | NCT01984697 | Human Papilloma... | V503 (9-valent ... | 9 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Cervical Cancer Screening Strategies | NCT05309122 | Cervical Cancer Cervical Intrae... Human Papilloma... Cervical Cytolo... Cancer Screenin... | 18 Years - | Peking Union Medical College Hospital | ||
| Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers | NCT00925288 | Human Papilloma... | Gardasil | 18 Years - 26 Years | Johns Hopkins Bloomberg School of Public Health | |
| HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs | NCT04133610 | Cervical Cancer Cervical Dyspla... Human Papilloma... | Self-sampling u... Self-sampling u... | 30 Years - 64 Years | The Institute of Molecular and Translational Medicine, Czech Republic | |
| A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection | NCT02785289 | Human Papilloma... | Vaginal swab | 21 Years - 65 Years | University Hospital, Geneva | |
| Prevalence of Human Papillomavirus in Men Living in the Northern Plains | NCT01265212 | Human Papilloma... | 18 Years - 65 Years | Sanford Health | ||
| Prospective Evaluation of Self-Testing to Increase Screening | NCT03898167 | Cervical Cancer Human Papilloma... | Telephone Recal... Mailed HPV Self... Patient Navigat... | 30 Years - 65 Years | Baylor College of Medicine | |
| Impact of HPV Vaccination on Cervical High Grade Lesions in France | NCT04167501 | Human Papilloma... | biological samp... | 27 Years - 46 Years | Centre Hospitalier Universitaire de Besancon | |
| Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination | NCT03442062 | Human Papilloma... | Assessment Feed... Physician-to-ph... Active Interven... | - | University of North Carolina, Chapel Hill | |
| An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women | NCT02464358 | Human Papilloma... | IMB Interventio... Attention Contr... | 18 Years - 26 Years | University of Connecticut | |
| Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America | NCT00546078 | Infections, Pap... | Cervarix™ | 15 Years - 25 Years | GlaxoSmithKline | |
| Probiotc Lactobacillus Crispatus-M247 (Crispact®) Supplementation in the Sterilization of High-risk Human Papilloma (HPV-HR) Viruses | NCT06245486 | Human Papilloma... | Crispact® Placebo | 18 Years - 64 Years | Liaquat University of Medical & Health Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
